Carina Biotech Doses First Patient in Phase 1/2a Clinical

First patient dosed in Australia where 3 clinical trial sites have been activated.The trial will enrol advanced colorectal cancer patients whose cancer...

Related Keywords

Adelaide ,South Australia ,Australia ,Australian ,Australians ,Rudi Michelson ,Deborah Rathjen ,Michael Brown ,Stephanie Carrington ,Jose Iglesias ,Carina Biotech Limited ,Monsoon Communications ,Biotech Limited ,New Drug ,Bayesian Optimal Interval ,Recommended Phase ,Deborah Rathjen Phd ,Chief Executive ,Chief Medical Officer Dr Jose Iglesias ,Principal Investigator ,Royal Adelaide Hospital ,Professor Michael Brown ,Carina Biotech ,